CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 8-K Event Results of operations
- 4 Grant or award Chief Financial Officer acquired 12,500 shares (grant or award)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 23,687 shares at an average $31.02 ($734,805)
- 4 Planned sale Chief Legal Officer sold 3,401 shares at $32.12 ($109,240)
- 4 Planned sale Chief Financial Officer sold 5,446 shares at $32.12 ($174,926)
- 4 Planned sale CEO sold 18,102 shares at $32.13 ($581,617)
- 4 Planned sale President sold 4,534 shares at $32.12 ($145,632)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Financial Officer acquired 27,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
- 4 Grant or award President acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 27,500 shares (grant or award)
Page 11 of 26 · 514 filings